Published in Cardiovascular Device Liability Week, September 19th, 2004
The research was performed by Stephen Epstein, MD and Jianhui Zhu, PhD at the Washington Hospital Center, Washington, D.C.
"AHA is the leading cardiac organization and we are privileged to have a nanobacterial talk at a conference of this caliber," said John Stanton, Nanobac's CEO. "Having our NB2 test results discussed in an oral session shows growing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.